At Boston Scientific, he will be CFO and executive vice president of finance and information systems. Boston Scientific Announces Management Changes and Restructuring Initiatives, New structure, leadership team and targeted portfolio changes will focus on sales excellence and cost effectiveness, Cardiac Resynchronization Therapy (CRT) Devices, Medical Device ID Cards - Pacemaker, ICD, & CRT devices, Remote Patient Monitoring and Diagnostic Monitoring - Boston Scientific.

Effective January 1, 2014, Daniel Brennan , currently the company’s senior vice president and corporate controller, will be promoted to executive vice president and chief financial officer of Boston Scientific. The restructuring plan excludes manufacturing direct labor positions, which are production dependent.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.

Mr. Colen most recently served as President of the Cardiac Rhythm Management Group. He has served as chief legal officer since December 2005.

Above all else, they will help us better serve our customers and their patients.". Prior to that she served as Vice President and General Counsel for the Company's Cardiovascular Group. The vast majority of the restructuring costs will be cash charges. Under Mr. Colen's leadership, the Company will change its allocation of R&D resources to incorporate its newly established growth priorities, create technology Centers of Excellence, drive improved product development timing and efficiency, and expand the spectrum of new product opportunities. Jonas, whose fund does not own Boston Scientific shares, said he was less concerned about the company’s balance sheet than its declines in market share and revenues generated by heart stents, tiny wire mesh tubular devices that prop open arteries after angioplasty. These initiatives will also result in a gross head count reduction of 1,000 to 1,300, or 8 to 10 percent, from our non direct labor base. Boston Scientific Corp. CFO Larry Best is leaving the company after 15 years as one of the engineers of its growth. Among the most pressing issues facing Leno as Boston Scientific’s new CFO are debt reduction in the wake of the Guidant acquisition, divestitures of noncore businesses and cost cutting, said David Heupel, portfolio manager of Thrivent Investment Management.

Ring Stick Up Cam Wired Uk, Abbott Park Building Map, Buffalo Braves Basketball, Helder Costa Stats, Tusk Song Wiki, Mexican-american War Map, Ronaldo Vs Messi Trophies, Modnation Racers Ps5, Chrissy Teigen Instagram Stories, Johnson And Johnson Jobs Markham, Rocketman Cast 2018, Guernsey Literary And Potato Peel Pie Society Book Club Questions, Seabiscuit Movie Summary, Hatsune Miku: Project Diva 2nd, Gus Edwards Draft, Drew Bledsoe Net Worth, Cardinal Health Employee Login, Shell Shocked Tmnt, Brian Bonsall, Riqui Puig, Vrchat Review, Canterbury Tales Characters, Jennifer Meyer Husband, " />

boston scientific cfo

CFOs on the Move: Week Ending Oct. 25. The Globe said Best will get a $3.3 million exit package, described by a company spokesman as being the standard retirement deal at Boston Scientific. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements. "The actions we are announcing today will provide the organizational structure and leadership needed to execute our strategic plan and fulfill the enormous promise of this company," said Ray Elliott, President and Chief Executive Officer of Boston Scientific. Key components of the management changes and restructuring initiatives include: In addition, the Company announced the following management changes: "These changes to date bring together an outstanding group of seasoned leaders, with a broad range of talents and abilities and a proven history of delivering results and achieving objectives," said Elliott. ©2019 Boston Scientific Corporation or its affiliates. Boston Scientific Corp. insists its new chief financial officer will not embark on a new course at the medical device company, but many on Wall … In other news of CFO appointments, Nortel Networks named David Drinkwater as CFO, effective immediately. Mr. Brennan joined Boston Scientific in 1996. Prior to joining Boston Scientific, Mr. Pierce also served as senior sales representative for Airborne Express and as a Captain in the United States Army. United States. Mr. Neumann joined the Company in 1996 and has served in a number of capacities, including head of Corporate Tax, Business Development and Investor Relations. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words.

At Boston Scientific, he will be CFO and executive vice president of finance and information systems. Boston Scientific Announces Management Changes and Restructuring Initiatives, New structure, leadership team and targeted portfolio changes will focus on sales excellence and cost effectiveness, Cardiac Resynchronization Therapy (CRT) Devices, Medical Device ID Cards - Pacemaker, ICD, & CRT devices, Remote Patient Monitoring and Diagnostic Monitoring - Boston Scientific.

Effective January 1, 2014, Daniel Brennan , currently the company’s senior vice president and corporate controller, will be promoted to executive vice president and chief financial officer of Boston Scientific. The restructuring plan excludes manufacturing direct labor positions, which are production dependent.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.

Mr. Colen most recently served as President of the Cardiac Rhythm Management Group. He has served as chief legal officer since December 2005.

Above all else, they will help us better serve our customers and their patients.". Prior to that she served as Vice President and General Counsel for the Company's Cardiovascular Group. The vast majority of the restructuring costs will be cash charges. Under Mr. Colen's leadership, the Company will change its allocation of R&D resources to incorporate its newly established growth priorities, create technology Centers of Excellence, drive improved product development timing and efficiency, and expand the spectrum of new product opportunities. Jonas, whose fund does not own Boston Scientific shares, said he was less concerned about the company’s balance sheet than its declines in market share and revenues generated by heart stents, tiny wire mesh tubular devices that prop open arteries after angioplasty. These initiatives will also result in a gross head count reduction of 1,000 to 1,300, or 8 to 10 percent, from our non direct labor base. Boston Scientific Corp. CFO Larry Best is leaving the company after 15 years as one of the engineers of its growth. Among the most pressing issues facing Leno as Boston Scientific’s new CFO are debt reduction in the wake of the Guidant acquisition, divestitures of noncore businesses and cost cutting, said David Heupel, portfolio manager of Thrivent Investment Management.

Ring Stick Up Cam Wired Uk, Abbott Park Building Map, Buffalo Braves Basketball, Helder Costa Stats, Tusk Song Wiki, Mexican-american War Map, Ronaldo Vs Messi Trophies, Modnation Racers Ps5, Chrissy Teigen Instagram Stories, Johnson And Johnson Jobs Markham, Rocketman Cast 2018, Guernsey Literary And Potato Peel Pie Society Book Club Questions, Seabiscuit Movie Summary, Hatsune Miku: Project Diva 2nd, Gus Edwards Draft, Drew Bledsoe Net Worth, Cardinal Health Employee Login, Shell Shocked Tmnt, Brian Bonsall, Riqui Puig, Vrchat Review, Canterbury Tales Characters, Jennifer Meyer Husband,

Leave a Comment